Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereof
A substituted amino heterocyclic carboxamide compound as represent by formula (Φ), or a pharmaceutically acceptable salt, a prodrug, a hydrate or a solvent compound, a crystal form, a stereoisomer or an isotopic variant of the compound, and a pharmaceutical composition thereof, and the use thereof a...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
29.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A substituted amino heterocyclic carboxamide compound as represent by formula (Φ), or a pharmaceutically acceptable salt, a prodrug, a hydrate or a solvent compound, a crystal form, a stereoisomer or an isotopic variant of the compound, and a pharmaceutical composition thereof, and the use thereof as an FLT3/AXL kinase inhibitor for treating acute myelocytic leukemia. |
---|---|
Bibliography: | Application Number: US201916971128 |